Use of a multi-gene pharmacogenetic panel reduces adverse drug effects

por Cavallari, Larisa H., Johnson, Julie A.
Publicado 2023

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hype...

por Chekka, Lakshmi Manasa S., Langaee, Taimour, Johnson, Julie A.
Publicado 2022

Whole Transcriptome Profiling: An RNA‐Seq Primer and Implications for Pharmacogenomics Research

por Sá, Ana Caroline C., Sadee, Wolfgang, Johnson, Julie A.
Publicado 2017

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

por El Rouby, Nihal, Lima, John J., Johnson, Julie A.
Publicado 2018

A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps

por Eken, Eda, Estores, David S, Cicali, Emily J, Wiisanen, Kristin K, Johnson, Julie A
Publicado 2023

A Novel Simple Method for Determining CYP2D6 Gene Copy Number and Identifying Allele(s) with Duplication/Multiplication

por Langaee, Taimour, Hamadeh, Issam, Chapman, Arlene B., Gums, John G., Johnson, Julie A.
Publicado 2015

Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients

por Chekka, Lakshmi Manasa S., Cooper‐DeHoff, Rhonda M., Gums, John G., Chapman, Arlene B., Johnson, Julie A.
Publicado 2022

Chromosome 7 and 19 Trisomy in Cultured Human Neural Progenitor Cells

por Sareen, Dhruv, McMillan, Erin, Ebert, Allison D., Shelley, Brandon C., Johnson, Julie A., Meisner, Lorraine F., Svendsen, Clive N.
Publicado 2009

Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial

por French, Benjamin, Joo, Jungnam, Geller, Nancy L, Kimmel, Stephen E, Rosenberg, Yves, Anderson, Jeffrey L, Gage, Brian F, Johnson, Julie A, Ellenberg, Jonas H
Publicado 2010

Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy

por Gerhard, Tobias, Delaney, Joseph AC, Cooper-DeHoff, Rhonda M, Shuster, Jonathan, Brumback, Babette A, Johnson, Julie A, Pepine, Carl J, Winterstein, Almut G
Publicado 2012

Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients

por Mehanna, Mai, McDonough, Caitrin W., Smith, Steven M., Gong, Yan, Gums, John G., Chapman, Arlene B., Johnson, Julie A., Cooper-DeHoff, Rhonda M.
Publicado 2022

2235: Equipping health professional students to apply pharmacogenomic data to clinical decision making in real-world scenarios: Comparison of an active engagement Versus didactic t...

por Arwood, Meghan J., Rowe McDonough, Caitrin, Cavallari, Larisa H., Elsey, Amanda R., Frye, Reginald F., Gong, Yan, Johnson, Julie A., Weitzel, Kristin W., Langaee, Taimour
Publicado 2018

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response

por Turner, Stephen T, Schwartz, Gary L, Chapman, Arlene B, Beitelshees, Amber L, Gums, John G, Cooper-DeHoff, Rhonda M, Boerwinkle, Eric, Johnson, Julie A, Bailey, Kent R
Publicado 2012

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

por El Rouby, Nihal, Alrwisan, Adel, Langaee, Taimour, Lipori, Gloria, Angiolillo, Dominick J, Franchi, Francesco, Riva, Alberto, Elsey, Amanda, Johnson, Julie A., Cavallari, Larisa H., Winterstein, Almut G.
Publicado 2020

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients

por Mehanna, Mai, McDonough, Caitrin W., Smith, Steven M., Gong, Yan, Gums, John G., Chapman, Arlene B., Johnson, Julie A., McIntyre, Lauren, Cooper-DeHoff, Rhonda M.
Publicado 2021

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals

por Le, MyPhuong T., Lobmeyer, Maximilian T., Campbell, Marcus, Cheng, Jing, Wang, Zhiying, Turner, Stephen T., Chapman, Arlene B., Boerwinkle, Eric, Gums, John G., Gong, Yan, Johnson, Richard J., Johnson, Julie A.
Publicado 2013

Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response

por Singh, Sonal, McDonough, Caitrin W., Gong, Yan, Bailey, Kent R., Boerwinkle, Eric, Chapman, Arlene B., Gums, John G., Turner, Stephen T., Cooper-DeHoff, Rhonda M., Johnson, Julie A.
Publicado 2019

Impact of CYP2D6 polymorphisms on clinical efficacy & tolerability of metoprolol tartrate

por Hamadeh, Issam S., Langaee, Taimour Y., Dwivedi, Ruti, Garcia, Sofia, Burkley, Ben M., Chapman, Arlene B., Gums, John G., Turner, Stephen T., Gong, Yan, Cooper-DeHoff, Rhonda M., Johnson, Julie A.
Publicado 2014

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

por Cavallari, Larisa H., Franchi, Francesco, Rollini, Fabiana, Been, Latonya, Rivas, Andrea, Agarwal, Malhar, Smith, D. Max, Newsom, Kimberly, Gong, Yan, Elsey, Amanda R., Starostik, Petr, Johnson, Julie A., Angiolillo, Dominick J.
Publicado 2018

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers

por Cunningham, Patrick N., Wang, Zhiying, Grove, Megan L., Cooper-DeHoff, Rhonda M., Beitelshees, Amber L., Gong, Yan, Gums, John G., Johnson, Julie A., Turner, Stephen T., Boerwinkle, Eric, Chapman, Arlene B.
Publicado 2019